Cargando…
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries
SUMMARY: A population-level, cross-sectional model was developed to estimate the clinical and economic burden of osteoporosis among women (≥ 70 years) across eight European countries. Results demonstrated that interventions aimed at improving fracture risk assessment and adherence would save 15.2% o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188417/ https://www.ncbi.nlm.nih.gov/pubmed/37191892 http://dx.doi.org/10.1007/s11657-023-01230-0 |
_version_ | 1785042907946811392 |
---|---|
author | Yeh, Eric J. Gitlin, Matthew Sorio, Francesc McCloskey, Eugene |
author_facet | Yeh, Eric J. Gitlin, Matthew Sorio, Francesc McCloskey, Eugene |
author_sort | Yeh, Eric J. |
collection | PubMed |
description | SUMMARY: A population-level, cross-sectional model was developed to estimate the clinical and economic burden of osteoporosis among women (≥ 70 years) across eight European countries. Results demonstrated that interventions aimed at improving fracture risk assessment and adherence would save 15.2% of annual costs in 2040. PURPOSE: Osteoporosis is associated with significant clinical and economic burden, expected to further increase with an ageing population. This modelling analysis assessed clinical and economic outcomes under different hypothetical disease management interventions to reduce this burden. METHODS: A population-level, cross-sectional cohort model was developed to estimate numbers of incident fractures and direct costs of care among women (≥ 70 years) in eight European countries under different hypothetical interventions: (1) an improvement in the risk assessment rate, (2) an improvement in the treatment adherence rate and (3) a combination of interventions 1 and 2. A 50% improvement from the status quo, based on existing disease management patterns, was evaluated in the main analysis; scenario analyses evaluated improvement of either 10 or 100%. RESULTS: Based on existing disease management patterns, a 44% increase in the annual number of fractures and costs was predicted from 2020 to 2040: from 1.2 million fractures and €12.8 billion in 2020 to 1.8 million fractures and €18.4 billion in 2040. Intervention 3 provided the greatest fracture reduction and cost savings (a decrease of 17.9% and 15.2% in fractures and cost, respectively) in 2040 compared with intervention 1 (decreases of 8.7% and 7.0% in fractures and cost, respectively) and intervention 2 (10.0% and 8.8% reductions in fracture and cost, respectively). Scenario analyses showed similar patterns. CONCLUSION: These analyses suggest that interventions which improve fracture risk assessment and adherence to treatments would relieve the burden of osteoporosis, and that a combination strategy would achieve greatest benefits. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11657-023-01230-0. |
format | Online Article Text |
id | pubmed-10188417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-101884172023-05-18 Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries Yeh, Eric J. Gitlin, Matthew Sorio, Francesc McCloskey, Eugene Arch Osteoporos Original Article SUMMARY: A population-level, cross-sectional model was developed to estimate the clinical and economic burden of osteoporosis among women (≥ 70 years) across eight European countries. Results demonstrated that interventions aimed at improving fracture risk assessment and adherence would save 15.2% of annual costs in 2040. PURPOSE: Osteoporosis is associated with significant clinical and economic burden, expected to further increase with an ageing population. This modelling analysis assessed clinical and economic outcomes under different hypothetical disease management interventions to reduce this burden. METHODS: A population-level, cross-sectional cohort model was developed to estimate numbers of incident fractures and direct costs of care among women (≥ 70 years) in eight European countries under different hypothetical interventions: (1) an improvement in the risk assessment rate, (2) an improvement in the treatment adherence rate and (3) a combination of interventions 1 and 2. A 50% improvement from the status quo, based on existing disease management patterns, was evaluated in the main analysis; scenario analyses evaluated improvement of either 10 or 100%. RESULTS: Based on existing disease management patterns, a 44% increase in the annual number of fractures and costs was predicted from 2020 to 2040: from 1.2 million fractures and €12.8 billion in 2020 to 1.8 million fractures and €18.4 billion in 2040. Intervention 3 provided the greatest fracture reduction and cost savings (a decrease of 17.9% and 15.2% in fractures and cost, respectively) in 2040 compared with intervention 1 (decreases of 8.7% and 7.0% in fractures and cost, respectively) and intervention 2 (10.0% and 8.8% reductions in fracture and cost, respectively). Scenario analyses showed similar patterns. CONCLUSION: These analyses suggest that interventions which improve fracture risk assessment and adherence to treatments would relieve the burden of osteoporosis, and that a combination strategy would achieve greatest benefits. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11657-023-01230-0. Springer London 2023-05-16 2023 /pmc/articles/PMC10188417/ /pubmed/37191892 http://dx.doi.org/10.1007/s11657-023-01230-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Yeh, Eric J. Gitlin, Matthew Sorio, Francesc McCloskey, Eugene Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries |
title | Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries |
title_full | Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries |
title_fullStr | Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries |
title_full_unstemmed | Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries |
title_short | Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries |
title_sort | estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight european countries |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188417/ https://www.ncbi.nlm.nih.gov/pubmed/37191892 http://dx.doi.org/10.1007/s11657-023-01230-0 |
work_keys_str_mv | AT yehericj estimatingthefutureclinicalandeconomicbenefitsofimprovingosteoporosisdiagnosisandtreatmentamongpostmenopausalwomenacrosseighteuropeancountries AT gitlinmatthew estimatingthefutureclinicalandeconomicbenefitsofimprovingosteoporosisdiagnosisandtreatmentamongpostmenopausalwomenacrosseighteuropeancountries AT soriofrancesc estimatingthefutureclinicalandeconomicbenefitsofimprovingosteoporosisdiagnosisandtreatmentamongpostmenopausalwomenacrosseighteuropeancountries AT mccloskeyeugene estimatingthefutureclinicalandeconomicbenefitsofimprovingosteoporosisdiagnosisandtreatmentamongpostmenopausalwomenacrosseighteuropeancountries |